
Gerald A Soff MD
Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Chief, Classical Hematology Service, University of Miami Health System/Sylvester Comprehensive Cancer Center
Join to View Full Profile
1120 NW 14th StMiami, FL 33136
Phone+1 312-502-0180
Dr. Soff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1991
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1981 - 1984
Johns Hopkins University School of MedicineClass of 1981
Certifications & Licensure
FL State Medical License 2021 - 2027
NJ State Medical License 2018 - 2021
NY State Medical License 2006 - 2021
IL State Medical License 1991 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
Clinical Trials
- Study of Romiplostim for Chemotherapy Induced Thrombocytopenia Start of enrollment: 2014 Jan 30
- A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Start of enrollment: 2020 Dec 10
- Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma Start of enrollment: 2020 Dec 14
Publications & Presentations
PubMed
- Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I Study.Erel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, Ariela Noy, Andrew D Zelenetz
Cancers. 2026-01-06 - A Single Institutional Experience Using Romiplostim to Treat Therapy-Related Thrombocytopenia in Pediatric Solid Tumor Patients.Melanie D Degliuomini, Katherine Armstrong, Michael Curry, Audrey Mauguen, Shakeel Modak
Pediatric Blood & Cancer. 2025-11-01 - Association of risk factors for venous thromboembolism and overall survival in lung cancer.Thomas E Plate, Asaad Trabolsi, Rachel S Kronenfeld, Leticia E Campoverde, Dan Morgenstern-Kaplan
Blood Vessels, Thrombosis & Hemostasis. 2025-08-01
Press Mentions
May 2025 Sylvester Cancer Insights: Essential Tips and UpdatesMay 19th, 2025
Sylvester Cancer Tip Sheet - May 2025May 17th, 2025
Sylvester Comprehensive Cancer Center Unveils Key Insights for ASCO 2025May 1st, 2025
Grant Support
- Histone Deacetylase Inhibitors For Cancer TreatmentNational Cancer Institute2005
- Generation Of And Angiostatin Level In Prostate CancerNational Cancer Institute2001–2002
- Angiostatic Therapy For Breast Cancer--A TranslationalNational Cancer Institute2000–2002
- Angiostatin Level In Prostate CancerNational Cancer Institute2001
- Plasminogen/Angiostatin Converting EnzymeNational Cancer Institute1997–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









